NMDP to Present New Stem Cell Transplantation Data at the 2024 American Society of Clinical Oncology Annual Meeting
24 avr. 2024 10h43 HE
|
NMDP
NMDP to present new data on hematopoietic cell transplantation treatment effects in patients with hematological malignancies at ASCO.
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
16 avr. 2024 08h00 HE
|
Provectus Biopharmaceuticals Inc.
Names Ed Pershing as Chief Executive Officer and Dominic Rodrigues as President KNOXVILLE, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the...
The International Myeloma Foundation and Black Swan Research Initiative® Announce the Release of New iStopMM Cohort Study: A Multivariable Prediction Model for Bone Marrow Sampling on Individuals with MGUS
11 avr. 2024 08h45 HE
|
International Myeloma Foundation
IMF's groundbreaking iStopMM Cohort Study unveils predictive model for bone marrow sampling in MGUS, shaping early diagnosis and treatment.
University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs
10 avr. 2024 11h48 HE
|
University, Cancer and Blood Center
University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs.
Global Rare Disease Diagnostics Market Size is Estimated to Reach USD 71.2 Billion by 2031, Growing at a CAGR of 8.62%: Straits Research
12 févr. 2024 06h30 HE
|
Straits Research
New York, United States, Feb. 12, 2024 (GLOBE NEWSWIRE) -- This study examines the effects of uncommon diseases on a significant portion of the global population. There are over 7000 uncommon...
Trace Genomics CEO & Co-Founder Poornima Parameswaran Elected to the International Myeloma Foundation’s Board of Directors
08 févr. 2024 08h45 HE
|
International Myeloma Foundation
Trace Genomics CEO & Co-Founder Poornima Parameswaran Elected to the International Myeloma Foundation’s Board of Directors
Contract Research Organization Market revenue to hit USD 108 Billion by 2035, says Research Nester
15 janv. 2024 06h00 HE
|
Research Nester
New York , Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global contract research organization market size is slated to expand at 7% CAGR between 2023 and 2035. The market is poised to garner a revenue of...
Wugen Strengthens Executive Leadership Team with Appointment of Keith Vendola, M.D., M.B.A. as Chief Financial Officer
03 janv. 2024 08h00 HE
|
Wugen
Wugen Strengthens Executive Leadership Team with the Appointment of Keith Vendola, M.D., M.B.A. as Chief Financial Officer
Wugen Presents Latest Data from First-In-Human Phase 1/2 Trial of WU-CART-007 in Patients with Difficult-to-Treat Blood Cancers at American Society of Hematology Annual Meeting
11 déc. 2023 15h00 HE
|
Wugen
Wugen Presents Latest Data from First-In-Human Phase 1/2 Trial of WU-CART-007 in Patients with Difficult-to-Treat Blood Cancers at ASH 2023
Largest study to date of high-dose methotrexate associated acute kidney injury supports the use of Voraxaze® (glucarpidase)
11 déc. 2023 09h51 HE
|
BTG Specialty Pharmaceuticals
West Conshohocken, PA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announces the presentation of the largest study to date of patients with high-dose methotrexate (HDMTX)...